High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.7M
$1,740,409
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| EXAS |
EXACT SCIENCES CORP
|
Officer • EVP, Human Resources
Other
|
2026-02-27 | $19,617 | M | Form 4 |
|
EXAS
S
EXACT SCIENCES CORP
Herriott James
• Officer • SVP, General Counsel & Sec
10b5-1 Sell
2025-11-19
$70,000
|
||||||
| EXAS |
EXACT SCIENCES CORP
|
Officer • SVP, General Counsel & Sec
10b5-1 Sell
|
2025-11-19 | $70,000 | S | Form 4 |
|
EXAS
S
EXACT SCIENCES CORP
ORVILLE JACOB A
• Officer • EVP, GM, Screening
10b5-1 SellΔOwn -17.7%
2025-11-19
$375,000
|
||||||
| EXAS |
EXACT SCIENCES CORP
|
Officer • EVP, GM, Screening
10b5-1 SellΔOwn -17.7%
|
2025-11-19 | $375,000 | S | Form 4 |
|
EXAS
S
EXACT SCIENCES CORP
Baranick Brian
• Officer • EVP, GM, Precision Oncology
10b5-1 SellΔOwn -11.3%
2025-11-04
$200,289
|
||||||
| EXAS |
EXACT SCIENCES CORP
|
Officer • EVP, GM, Precision Oncology
10b5-1 SellΔOwn -11.3%
|
2025-11-04 | $200,289 | S | Form 4 |
|
EXAS
S
EXACT SCIENCES CORP
Herriott James
• Officer • SVP, General Counsel & Sec
10b5-1 SellΔOwn -10.7%
2025-11-04
$105,120
|
||||||
| EXAS |
EXACT SCIENCES CORP
|
Officer • SVP, General Counsel & Sec
10b5-1 SellΔOwn -10.7%
|
2025-11-04 | $105,120 | S | Form 4 |
|
EXAS
S
EXACT SCIENCES CORP
Zanotti Katherine S
• Director
10b5-1 SellΔOwn -16.5%
2025-10-24
$780,000
|
||||||
| EXAS |
EXACT SCIENCES CORP
|
Director
10b5-1 SellΔOwn -16.5%
|
2025-10-24 | $780,000 | S | Form 4 |
| EXAS |
EXACT SCIENCES CORP
|
Director
10b5-1 Sell
|
2025-10-09 | $120,000 | S | Form 4 |
|
EXAS
S
EXACT SCIENCES CORP
Herriott James
• Officer • SVP, General Counsel & Sec
10b5-1 Sell
2025-10-09
$90,000
|
||||||
| EXAS |
EXACT SCIENCES CORP
|
Officer • SVP, General Counsel & Sec
10b5-1 Sell
|
2025-10-09 | $90,000 | S | Form 4 |